Photo of Motomi (Tomi) Mori, Ph.D., M.B.A.

Motomi (Tomi) Mori Ph.D., M.B.A.

  • (503) 418-1555
    • Professor OHSU-PSU School of Public Health
    • Walter & Cora Brownfield Professor of Cancer Biostatistics
    • OHSU Knight Cancer Institute School of Medicine
    • Medical Informatics and Clinical Epidemiology School of Medicine

Dr. Mori has 28 years of experience as a collaborative cancer biostatistician, starting with the Fred Hutchinson Cancer Research Center (1989-1991), Huntsman Cancer Institute at the University of Utah (1991-1999), and the Knight Cancer Institute (Knight) at the Oregon Health & Science University (1999-present). As the Director of the Knight Biostatistics Shared Resource, she has a long standing collaboration with investigators in the Translational Oncology Program and the Cancer Prevention and Control Program in the Knight Cancer Institute. She holds a position of Walter and Clora Brownfield Endowed Professor of Cancer Biostatistics in the Knight Cancer Institute, is an elected Fellow of the American Statistical Association, President of the Western North American Region of the International Biometric Society (IBS), served on the NCI Subcommittee A (Cancer Centers of the National Cancer Institute Initial Review Group (2006-2011) and was a faculty for the AACR/ASCO Methods in Clinical Research Workshop in Vail, Colorado (2015-2017).

Areas of interest

  • Biostatistics, cancer research, clinical trials, precision oncology, early detection research

Education

  • Ph.D., Biostatistics, University of Iowa, Iowa City Iowa 1989
  • M.B.A., Healthcare Management, Oregon Health & Science University, Portland Oregon 2016

Honors and awards

  • 2010 Fellow, American Statistical Association
  • 2005 Outstanding Alumni Award, College of Public Health, University of Iowa

Memberships and associations

  • American Statistical Association
  • International Biometric Society
  • American Association for Cancer Research
  • American Association for the Advancement of Science
  • American Society of Clinical Oncology

Publications

  • "Patient activation and improved outcomes in HIV-infected patients" Journal of General Internal Medicine May 2013
  • "CD8 + T cells provide an immunologic signature of tuberculosis in young children" American Journal of Respiratory and Critical Care Medicine January 15 2012
  • "Interest in physician-assisted suicide among Oregon cancer patients" Journal of Clinical Ethics March 2006
  • "Cost of nosocomial infection" American Journal of Infection Control  1988
  • "Personalized cancer care" Pediatric Blood and Cancer July 15 2012
  • "A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with previously untreated gastric adenocarcinoma" Annals of Oncology  2001
  • "Hospital-acquired pneumonia" American Journal of Epidemiology June 1989
  • "Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens" Journal of Clinical Oncology  1993
  • "Loss of naive T cells and repertoire constriction predict poor response to vaccination in old primates" Journal of Immunology June 15 2010
  • "Nosocomial gram-negative bloodstream isolates" Journal of Hospital Infection  1989
  • "Late complications of allogeneic and autologous marrow transplantation" Bone Marrow Transplantation  1992
  • "Association of ambulatory use of statins and beta-blockers with long-term mortality after vascular surgery" Journal of hospital medicine (Online) July 2007
  • "Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant" Blood July 1 1991
  • "Quality of life in women with postpartum anal incontinence" Obstetrics and Gynecology April 2010
  • "Etiology and outcome of diarrhea after marrow transplantation" Gastroenterology  1994
  • "C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer" Cancer June 1 2008
  • "Documentation and management of CKD in rural primary care" Clinical Journal of the American Society of Nephrology May 7 2013
  • "Dramatic increase in naïve T cell turnover is linked to loss of naïve T cells from old primates" Proceedings of the National Academy of Sciences of the United States of America December 11 2007
  • "Assessment of Prostate-Specific Antigen Doubling Time in Prediction of Prostate Cancer on Needle Biopsy" Urology May 2007
  • "Slope estimation in the presence of informative right censoring" Biometrics  1994
  • "Classification and regression tree analysis for the prediction of aggressive prostate cancer on biopsy" Journal of Urology March 2006
  • "Evolving Preoperative Evaluation of Patients with Pancreatic Cancer" Journal of the American College of Surgeons January 2009
  • "Age-stratified serum levels of isoflavones and proportion of equol producers in Japanese and Korean healthy men" Prostate Cancer and Prostatic Diseases  2008
  • "Recombinant human granulocyte colony-stimulating factor accelerates hematopoietic recovery after DLA-identical littermate marrow transplants in dogs" Blood August 1 1990
  • "Variation in physician opinion about scheduling of return visits for common ambulatory care conditions" Journal of General Internal Medicine May 1992
  • "Impact of racial genetic polymorphism on the probability of finding an hla-matched donor" Transplantation October 27 1995
  • "Hospital-Acquired Candidemia" JAMA Internal Medicine  1988
  • "GABAergic system gene expression predicts clinical outcome in patients with neuroblastoma" Journal of Clinical Oncology  2004
  • "Comparison of antibiograms developed for inpatients and primary care outpatients" Diagnostic Microbiology and Infectious Disease May 2013
  • "Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels ≤ 10 ng/ml" Cancer October 1 2003

Additional information

Edit profile